Company / Cash per Share
Coherus Oncology, Inc. Cash per Share History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$2.60
FY2019
5-year range
$1.19 / $3.86
FY2015-FY2019
Trend
+115.1%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share returned to growth in FY2019 after 2 years of decline, reaching $2.60.
Based on SEC 10-K filings.
2.60 in FY2019 with a 5-year CAGR of -2.9%.
Declined from $2.77 to $2.60 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -12.3%
- 5-Year CAGR
- -2.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, cash per share increased 115.1% year-over-year.
- Peak cash per share was recorded in FY2016.
- Lowest cash per share in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -0.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $2.60 | +115.1% |
| FY2018 | $1.21 | -56.4% |
| FY2017 | $2.77 | -28.1% |
| FY2016 | $3.86 | +224.2% |
| FY2015 | $1.19 | -60.5% |
| FY2014 | $3.01 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026